Barbara Hanney

436 total citations
8 papers, 221 citations indexed

About

Barbara Hanney is a scholar working on Molecular Biology, Hematology and Organic Chemistry. According to data from OpenAlex, Barbara Hanney has authored 8 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Hematology and 1 paper in Organic Chemistry. Recurrent topics in Barbara Hanney's work include Blood Coagulation and Thrombosis Mechanisms (2 papers), Phosphodiesterase function and regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Barbara Hanney is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (2 papers), Phosphodiesterase function and regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Barbara Hanney collaborates with scholars based in United States and United Kingdom. Barbara Hanney's co-authors include Alfred P. Spada, Saul Needle, Glenda E. Bilder, Dilip Amin, He Wang, Zaid Jayyosi, Ken Page, Wei He, Michael R. Myers and Stevan W. Djurić and has published in prestigious journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.

In The Last Decade

Barbara Hanney

8 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Hanney United States 6 187 45 17 11 6 8 221
Antonella Ursini Italy 10 269 1.4× 69 1.5× 17 1.0× 4 0.4× 3 0.5× 23 314
Dmytro O. Tymoshenko United States 11 294 1.6× 106 2.4× 10 0.6× 3 0.3× 3 0.5× 30 318
Caroline Meyers Belgium 10 384 2.1× 129 2.9× 16 0.9× 4 0.4× 4 0.7× 14 410
Lalgudi S. Harikrishnan United States 7 115 0.6× 73 1.6× 8 0.5× 5 0.5× 3 0.5× 14 163
Marie‐Christine Brochu Canada 4 463 2.5× 35 0.8× 22 1.3× 9 0.8× 3 0.5× 5 499
Kai Xie China 13 610 3.3× 42 0.9× 17 1.0× 2 0.2× 4 0.7× 25 643
Abdel‐Aziz S. El‐Ahl Egypt 12 367 2.0× 70 1.6× 37 2.2× 4 0.4× 16 2.7× 25 393
D. David Hennings United States 6 349 1.9× 38 0.8× 22 1.3× 2 0.2× 3 0.5× 12 385
Preeti Wadhwa India 10 441 2.4× 98 2.2× 18 1.1× 5 0.5× 3 0.5× 14 457
Corinne Comoy France 10 258 1.4× 95 2.1× 25 1.5× 5 0.5× 6 1.0× 31 312

Countries citing papers authored by Barbara Hanney

Since Specialization
Citations

This map shows the geographic impact of Barbara Hanney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hanney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hanney more than expected).

Fields of papers citing papers by Barbara Hanney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Hanney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hanney. The network helps show where Barbara Hanney may publish in the future.

Co-authorship network of co-authors of Barbara Hanney

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Hanney. A scholar is included among the top collaborators of Barbara Hanney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Hanney. Barbara Hanney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Perkins, James J., Paul McQuade, Christopher J. Bungard, et al.. (2023). Discovery of [11C]MK-8056: A Selective PET Imaging Agent for the Study of mGluR2 Negative Allosteric Modulators. ACS Medicinal Chemistry Letters. 14(7). 986–992. 2 indexed citations
2.
Wang, He, Barbara Hanney, Alfred P. Spada, et al.. (2003). Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 2: the synthesis and biological activities of RPR127963 an orally bioavailable inhibitor. Bioorganic & Medicinal Chemistry Letters. 13(18). 3097–3100. 136 indexed citations
3.
Myers, Michael R., Wei He, Barbara Hanney, et al.. (2003). Potent quinoxaline-Based inhibitors of PDGF receptor tyrosine kinase activity. Part 1: SAR Exploration and Effective Bioisosteric Replacement of a phenyl substituent. Bioorganic & Medicinal Chemistry Letters. 13(18). 3091–3095. 35 indexed citations
4.
He, Wei, Barbara Hanney, Michael R. Myers, et al.. (2002). Benzimidazoles and isosteric compounds as potent and selective factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(6). 919–922. 6 indexed citations
5.
He, Wei, Barbara Hanney, Michael R. Myers, et al.. (2000). Nonbenzamidine compounds as selective factor xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(15). 1737–1739. 10 indexed citations
6.
He, Wei, Fu‐Chih Huang, John R. Regan, et al.. (1999). Novel cytokine release inhibitors. Part IV: Analogs of podocarpic acid. Bioorganic & Medicinal Chemistry Letters. 9(3). 469–474. 5 indexed citations
7.
Regan, John R., Joseph G. Bruno, Daniel McGarry, et al.. (1998). 2-Substituted-4-methoxybenzimidazole-based PDE4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(19). 2737–2742. 8 indexed citations
8.
Huang, Fu‐Chih, Barbara Hanney, John E. Souness, et al.. (1998). Novel Cyclic Compounds as Potent Phosphodiesterase 4 Inhibitors. Journal of Medicinal Chemistry. 41(22). 4216–4223. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026